Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granulocyte colony-stimulating factor in ICSI patients with repeated implantation failure
IRCT201108212576N5Phase 2Completed
- Sponsor
- Tums
- Start
- Dec 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of filgrastim in Recurrent Implantation Failure (RIF), sponsored by Tums. Started Dec 2011; status: completed.
02
Drugs
filgrastim
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT201108212576N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108212576N5.